Biomarkers found for postmenopausal cardiovascular disease

Jul 27, 2010

Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.

Ross Prentice, from the Fred Hutchinson Cancer Research Centre, Seattle, USA, worked with a team of researchers to carry out proteomic analyses on samples from 800 women who developed CHD, 800 who developed and a group of matched controls. He said, "We contrasted pools formed by equal plasma volumes from 100 cases or from 100 pair-matched controls, with eight such pool pairs for each of the study diseases. The two novel markers we identified, B2M and IGFBP4, have the potential to help elucidate hormone therapy effects on the cardiovascular diseases as observed in the WHI randomized controlled trials".

B2M has previously been associated with CHD risk factors including age, blood pressure, and C-reactive , and has been reported to show an inverse association with high-density lipoprotein (HDL) cholesterol. According to Prentice, "Our finding of B2M elevation in plasma obtained months or years prior to CHD diagnosis appears to be novel, however". The identification of IGFBP4 as a risk marker for stroke in postmenopausal women also appears to be a novel finding.

Speaking about the results, Prentice said, " concentrations provide a source for novel disease risk markers that may be modifiable by treatments or other exposures. As such, protein markers have potential to enhance the understanding of , and to elucidate biological processes whereby an exposure affects disease risk."

Explore further: Genes may help explain why some people are naturally more interested in music than others

More information: Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling, Ross L Prentice, Sophie J Paczesny, Aaron Aragaki, Lynn M Amon, Lin Chen, Sharon J Pitteri, Martin McIntosh, Pei Wang, Tina Busald Buson, Judith Hsia, Rebecca D Jackson, Jacques E Rossouw, JoAnn E Manson, Karen Johnson, Charles Eaton and Samir M Hanash, Genome Medicine (in press), genomemedicine.com/

add to favorites email to friend print save as pdf

Related Stories

Protein effects of hormone replacement therapy uncovered

Apr 29, 2009

An in-depth proteomic analysis of the sera of 50 participants from the Women's Health Initiative (WHI) hormone replacement therapy trial provides some explanations for the trial's clinical results. The study, published in ...

Trends in heart mortality reversing in younger women

May 01, 2008

Coronary heart disease mortality in younger women could be on the rise, according to findings in the open access journal, BMC Public Health, published by BioMed Central. High levels of smoking, increasing obesity and a lack ...

Lead in the blood increases women's mortality

Apr 02, 2009

Lead concentrations in the blood are associated with an increased risk of death from coronary heart diseases (CHD). A study of 533 American women, published in BioMed Central's open access journal Environmental Health, has sh ...

Recommended for you

Gene variant that dramatically reduces 'bad' lipids

9 hours ago

In the first study to emerge from the UK10K Project's cohort of samples from the general public, scientists have identified a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood. ...

New diagnostic method identifies genetic diseases

10 hours ago

People with genetic diseases often have to embark on an odyssey from one doctor to the next. Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. Scientists ...

User comments : 0